Keros Therapeutics (KROS) Asset Utilization Ratio (2020 - 2025)

Keros Therapeutics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.45 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 225179.88% year-over-year to 0.45; the trailing twelve-month figure through Dec 2025 stood at 0.45 (up 225179.88% YoY), and the FY2025 full-year result was 0.51, changed N/A from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.45, up from 0.32 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.45 in Q4 2025, with the low at 0.0 in Q4 2024.
• Historically, Asset Utilization Ratio has averaged 0.12 across 5 years, with a median of 0.06 in 2022.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio plunged 146.3% — and 2025, when it soared 225179.88%.
• Keros Therapeutics' Asset Utilization Ratio stood at 0.07 in 2021, then decreased by 13.25% to 0.06 in 2022, then slumped by 99.33% to 0.0 in 2023, then sank by 146.3% to 0.0 in 2024, then soared by 225179.88% to 0.45 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.45 (Q4 2025), 0.32 (Q3 2025), and 0.3 (Q2 2025), per Business Quant data.